Skip to content

Docs (opens in a new tab)Pricing Research Benchmark

Sign in Sign up

A

ARVN

Arvinas, Inc.

NASDAQHealthcareBiotechnologyUS

NASDAQ · Healthcare · Biotechnology · US

$9.41

+1.05%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsAnalysis

Research · Sep 3, 2026

ARVN: FY25 Deep Dive

Arvinas FY25 at $263M. NI $-81M; EPS $-1.28.

The idea engine
for fundamental investors.

Product

Ask drillr Watchlist

Resources

Research Methodology Benchmark Docs (opens in a new tab)

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Pricing Privacy Terms© 2026 LIL GREBE INC.